While reporting financial results for the third quarter on Friday, biopharmaceutical company Ligand Pharmaceuticals Inc. (LGND) reiterated its adjusted earnings and revenue guidance for the full-year 2020.
from RTT - Earnings https://ift.tt/2JmrL6j
via IFTTT
No comments:
Post a Comment